A quick leap of logic... If an institutional investor is

New Post Public Reply Private Reply Replies (0) Message Board
Respert24
951
A quick leap of logic...

If an institutional investor is willing to lend that much money at double our share price, they must like what they see. And what is it they see that is different from a week or two ago?

Results.

Something must have been shared with them because they aren’t investing that kind of money on a wing and a prayer. So, if they got a sneak peek at the (or some of the) results...what are the chances that the interested big pharma companies have also seen the same data?

So if the data is coming out behind closed doors, and it’s good, we could very well see some licensing/partnering deals announced at any minute too.

While it remains to be seen just how positive the data will be, I think this deal gives us a big reason to believe that at least some of the efficacy data is very good. I can’t wait for tomorrow to find out more!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 6

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 3

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
TCL’s AI Vision: Immersive Living at IFA 2026

Updated Category News Views 3

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 2

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 1

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 3

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading

Top 5 Most Recently Viewed Articles

Archer Aviation's Q4 Earnings Report: Key Insights and Future Plans

Updated Category News Views 344

Archer Aviation Reports Q4 Earnings and Future Plans Archer Aviation Inc (ACHR) has recently disclosed its financial results for the fourth quarter of the fiscal year. This report provides an in-depth look at crucial details associated with their recent earnings and future strategies. Understanding Archer's Q4 Financial Performance During the fourth quarter, Archer...

Continue Reading
Alvotech's Progress on FDA Review for AVT05 Biosimilar

Updated Category News Views 265

Alvotech's Update on AVT05 Biologics License Application Alvotech (NASDAQ: ALVO), a prominent global biotech firm dedicated to crafting biosimilar medicines, recently announced significant developments regarding its Biologics License Application (BLA) for AVT05. This biosimilar candidate, designed to imitate Simponi (golimumab), is being presented in both prefilled...

Continue Reading
Benzinga Honors Fintech Innovators at Capital Conference 2025

Updated Category News Views 199

Benzinga Celebrates the Best in Fintech Innovations Benzinga, a standout leader in financial media and data, held an extraordinary event celebrating the annual Fintech Awards. The event recognized remarkable achievements shaping the future of the financial sector, inspiring executives and innovators alike. A Night of Glorious Recognition The awards ceremony was a...

Continue Reading
Understanding the Decline in Eastern Bankshares Short Interest

Updated Category News Views 107

Overview of Eastern Bankshares Short Interest Eastern Bankshares EBC has witnessed a reduction in its short interest, which is a metric used by investors to gauge market sentiment. Recently, the short percent of float dropped by 3.96%. The company reported approximately 4.26 million shares sold short, equating to about 2.18% of all shares available for trading. Given its...

Continue Reading
Promising Results from enGene's Bladder Cancer Trial Excite Investors

Updated Category News Views 121

Excitement in the Air for enGene Holdings Inc. enGene Holdings Inc. (NASDAQ: ENGN) is experiencing a significant surge in its stock price as more promising data emerges from its ongoing clinical trials. As of the latest reporting period, the company's stock surged higher, showcasing a remarkable increase. This positive upward momentum coincides with the release of the new...

Continue Reading